SCHEMBL3601727

SCHEMBL3601727

C=CCC(O)c1nn(C)c(Oc2cc(OCc3ccc(OC)cc3)c(Cl)cc2Cl)c1C=C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 4/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
HPGD P15428 2/20 0.35
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
BRD4 O60885 1/20 0.33
POLB P06746 2/20 0.32
LMNA P02545 1/20 0.32
CYP3A4 P08684 1/20 0.32
FFAR1 O14842 1/20 0.32
CCR5 P51681 1/20 0.32
MRGPRX4 Q96LA9 1/20 0.32
ENPP2 Q13822 1/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 2/20 0.31
PPARG P37231 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3604950 0.91 ALDH1A1 (0.35) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL3604681 0.85 SMN1; SMN2 (0.40) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL3605167 0.83 ALDH1A1 (0.39) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL3603078 0.81 SMN1; SMN2 (0.38) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL3605828 0.80 ALDH1A1 (0.38) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL3610531 0.79 KDM4E (0.38) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL3604969 0.78 ALDH1A1 (0.39) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL3612420 0.78 SMN1; SMN2 (0.53) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL3610502 0.77 ALDH1A1 (0.39) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19
SCHEMBL3605696 0.76 ALDH1A1 (0.44) ALDH1A1KDM4ECYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100016396-A1 PYRAZOLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-01-21 US disclosed
EP-2128138-A1 PYRAZOLE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016396-A1 PYRAZOLE COMPOUND SLC5A1, SLC5A2, GLP1R ALDH1A1 365/4885KDM4E 2049/4885CYP1A2 137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.